Tau proteotasis in Alzheimer's disease

Area of Science:

• Neuroscience
• Cell Biology
• Biochemistry

Background:

• Alzheimer's disease (AD) is characterized by the accumulation of tau protein.
• Tau pathology progresses from soluble oligomers to insoluble neurofibrillary tangles.
• This aggregation leads to neuronal dysfunction and death.

Purpose of the Study:

• To investigate the cellular mechanisms responsible for clearing aggregated tau protein.
• To understand the role of proteostasis in managing tau toxicity in AD.
• To identify pathways involved in tau clearance.

Main Methods:

• Analysis of cellular machineries involved in protein degradation.
• Examination of the role of chaperone-co-chaperone complexes, ubiquitin, kinases, and proteases.
• Investigation of autophagy as a key clearance mechanism.
• Study of post-translational modifications and mutations affecting tau clearance.

Main Results:

• Cells employ specific pathways and proteins to clear aberrant tau.
• Proteostasis, encompassing protein synthesis, folding, and degradation, is vital for cellular health.
• Autophagy is identified as a critical mechanism for removing toxic tau aggregates.
• Tau clearance pathways are influenced by tau's post-translational modifications and mutations.

Conclusions:

• Effective tau clearance through proteostasis is essential for preventing neuronal death in AD.
• Dysregulation of proteostasis contributes to tau accumulation and AD pathogenesis.
• Targeting cellular clearance mechanisms may offer therapeutic strategies for AD.